Milestone Pharmaceuticals Inc. Interest Expense
Milestone Pharmaceuticals Inc. (MIST) reported Interest Expense of $872.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-13
- Milestone Pharmaceuticals Inc. interest expense for the quarter ending 2024-03-31 was $872.00K, a 2542.42% increase year-over-year.
- Milestone Pharmaceuticals Inc. interest expense for the quarter ending 2023-12-31 was $857.00K.
- Milestone Pharmaceuticals Inc. interest expense for the quarter ending 2023-09-30 was $841.00K.
- Milestone Pharmaceuticals Inc. interest expense for the quarter ending 2023-06-30 was $820.00K.
- Milestone Pharmaceuticals Inc. interest expense for fiscal 2023 was $2.55M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $872.00K 10-Q · filed 2024-05-13 | $1.73M derived: sum of 2 quarters · filed 2024-05-13 | $2.57M derived: sum of 3 quarters · filed 2024-05-13 | $3.39M derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.70M derived: sum of 2 quarters · filed 2024-03-21 | $2.52M derived: sum of 3 quarters · filed 2024-03-21 | $2.55M 10-K · filed 2024-03-21 |
| 2023-09-30 | $841.00K 10-Q · filed 2023-11-13 | $1.66M derived: sum of 2 quarters · filed 2023-11-13 | $1.70M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $820.00K 10-Q · filed 2023-08-10 | $856.00K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |